AMT vs BCAX · P/E 31, rev $10.64B vs $1.51B cap
American Tower Corp (AMT) versus Bicara Therapeutics Inc. Common Stock (BCAX) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Bicara Therapeutics Inc. Common Stock (BCAX) is a biotechnology company listed on NASDAQ.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
BCAX does not have a complete income-statement cache yet.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. BCAX currently screens at market cap $1.51B.
Not investment advice. Open the AMT and BCAX stock pages for the full models.
Not investment advice.